QLT Inc. (QLTI)

Company

"QLT Inc. is a global biopharmaceutical company specializing in developing treatments for eye diseases as well as dermatological conditions. Together with our subsidiaries, we have combined our expertise in the discovery, development and commercialization of innovative drug therapies with our two unique technology platforms, photodynamic therapy and Atrigel®, to create products such as Visudyne® and Eligard®." (company website)

Buy

21-Sep-06. In August, QLTI moved up to the $7.50 level and has held mostly above that for nearly a month. It touched up with the lower Bollinger band two days ago and moved slightly higher again today at the open. The 50-day moving average recently crossed above the 200-day average.

• Price momentum (PPO) — strengthened significantly after low in June, but has weakened again during the pull back from latest high
• Trend (ADX) — weakening, with buying pressure (+DI) and selling pressure (-DI) about equal -- not really a good sign
• Money flow (CMF) — neutral again after strong inflow
• Relative strength (RSI) — was weakening but picking up again this week
• Volume — a little light and a little worrisome

Sell

19-Oct-06. The stop-loss order for QLTI was triggered last Thursday in the wild volatility that came when the company lowered its sales forecast for one of its products. I understand why that made the stock go down; I don't understand what made it go back up again the same day.

This is another case of the trailing stop-loss order working exactly the way it was supposed to, but resulting in leaving some money on the table. QLTI had closed over $8 after the buy, so that's 50¢ a share that got away.